Biomedical

Sanofi and Lonza initiated a joint venture in March of 2017 to create a $285 million biologics manufacturing center in Visp, Switzerland. The strategic partnership leverages Lonza’s expertise in designing, constructing, and managing large-scale mammalian cell culture facilities with Sanofi’s strength in the discovery and launch of biologics-based treatments. Construction is expected to begin in 2017 on the initial phase of the project, with full operations commencing by 2020.

The University of Arizona opened the $136 million Biosciences Partnership Building in February of 2017. Located on the Phoenix Biomedical Campus, the 10-story, 245,000-sf facility houses the Center for Applied NanoBioscience and Medicine, the Institute of Molecular Medicine, the Pediatric Infectious Disease Research Lab, the Research and Translational Flow Cytometry and Immunology Core Lab, and an advanced cancer research lab.

Mayo Clinic’s Department of Laboratory Medicine and Pathology (DLMP) has relocated and consolidated three laboratories—Endocrine, Toxicology and Drug Monitoring, and the Proteomics Core Mass Spectrometry Development Lab (CMSL)—into a singular core mass spectrometry laboratory. The two-story, 65,000-gsf addition to the Superior Drive Support Center (SDSC) is 10 to 15 minutes from Mayo Clinic’s downtown Rochester, Minn., campus.

Texas Tech University broke ground on the $77 million Experimental Sciences Building II in February of 2017 in Lubbock, Texas. Designed by TreanorHL to support interdisciplinary research, the collaborative 117,000-gsf facility will provide four general wet labs, three core instrumentation suites, two synthetic labs, a vivarium, a BSL-2 lab, conference rooms, and offices for researchers and principal investigators. The construction manager for the LEED-certified facility, which comprises four stories and a basement, is Project Control.

The Sheikha Salwa Sabah Al Ahmad Stem Cell and Umbilical Cord Center is being constructed in the Sabah Medical District in Kuwait. Designed by SSH, the $26 million facility will provide research and testing laboratories, an outpatient center for adult stem cell collection, a cryolab, and storage banks for stem and cord blood cells. The three-story, 84,000-sf project will also include medical libraries, a lecture hall, and a utility building. Completion is expected in September of 2017.

The International Society for Pharmaceutical Engineering (ISPE) announced the annual winners for the Facility of the Year Award (FOYA) program in February of 2017. The category winners were:

Central Michigan University opened the $95 million Biosciences Building in January of 2017 in Mount Pleasant. Designed by Stantec to promote interaction and collaboration, the four-story, 169,000-sf facility provides teaching labs, research labs, lecture halls, an active learning classroom, an auditorium, and faculty offices. The building also includes a BSL-3 suite, an herbarium, an imaging center, and an aquatic research vivarium. Clark Construction began work on the project in September of 2014.

Zymeworks opened a 10,000-sf biopharmaceutical laboratory in January of 2017 in Vancouver, British Columbia. The facility will provide a centralized location for the company’s discovery research operations, including antibody generation, medicinal chemistry, bioconjugation, and the development of multifunctional proteins. Zymeworks is a producer of therapeutic agents for clinical-stage research on the treatment of cancer.

The State University of New York at Binghamton is constructing the $60 million School of Pharmacy and Pharmaceutical Sciences in New York. Designed by The S/L/A/M Collaborative, the 105,000-sf building will provide sophisticated teaching and research labs, lecture halls, faculty offices, a library, and student activity space. Accommodating 240 students and approximately 36 faculty members, the four-story facility will feature interactive classrooms that can accommodate lectures as well as team-based learning activities.

The Jackson Laboratory is building the $21 million Center for Biometric Analysis in Bar Harbor, Maine. Designed by Harriman Associates, the 21,000-sf facility will support the precision analysis of disease markers in research mice through advanced imaging and analytical technologies. PC Construction broke ground on the project in June of 2016 and completion is expected by January of 2018. The construction cost of the facility is $14 million. 

Penn Medicine and Novartis have joined forces to create the new Center for Advanced Cellular Therapies (CACT), located atop the Henry Jordan Medical Education Center at the Perelman School of Medicine. Dedicated to finding more effective treatments for cancer using personalized medicine, this first-of-its-kind facility forms the epicenter for research using chimeric antigen receptor (CAR) technology, which enables a patient’s T cells to be removed, reprogrammed, and re-infused into the patient, where they can “hunt” and destroy cancer cells.

After a one-year delay, Congress has passed the 21st Century Cures Act, which includes new funding totaling $4.8 billion for the National Institutes of Health (NIH), $500 million for the Food and Drug Administration (FDA) to bring novel drug therapies and medical devices to market more quickly, and $1 billion to fight the growing opioid crisis. The NIH funding includes $1.8 billion for Vice President Joseph Biden’s “Cancer Moonshot,” $1.6 billion for President Obama’s BRAIN initiative, and additional money earmarked for precision medicine. The Cures Act funding is separate from, and in addition to, annual NIH budget increases. It comes on the heals of a $2 billion increase in NIH funding last year, the largest increase in a decade. If the trend continues, it could result in a need for additional research infrastructure in the form of renovations and new construction.

Imperial College London began construction in early 2017 on the £70 million Michael Uren Biomedical Engineering Research Hub in London. Designed by Allies & Morrison, the collaborative 14-story building will provide flexible laboratories, an outpatient clinic, an auditorium, and interaction spaces. Located on the White City campus, the 215,000-sf translational research facility will be built to attain BREEAM sustainable design certification and will feature a highly efficient service model with interconnected utility plants on each floor.

Los Angeles Biomedical Research Institute (LA Biomed) will begin construction in early 2017 on a four-story, 85,000-sf R&D facility on the campus of Harbor-UCLA Medical Center in Torrance, Calif. Consolidating operations currently dispersed in seven campus locations, the collaborative project will feature core labs with advanced technological instrumentation. A modular design will provide flexible wet and dry research spaces as well as conference and dining facilities.

The University of Melbourne is engaged in a 54,000-sf expansion of the Bio21 Molecular Science and Biotechnology Institute. Created in partnership with Australian biopharmaceutical firm CSL, the AUD$36.4 million project will house the CSL Global Hub for Research and Translational Medicine, which will feature advanced technologies for the creation of personalized medicine solutions. Completion is expected in mid-2017.